Cargando…
AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers
BACKGROUND: Obesity among older adults has increased tremendously. Obesity accelerates ageing and predisposes to age‐related conditions and diseases, such as loss of endurance capacity, insulin resistance and features of the metabolic syndrome. Namely, ectopic lipids play a key role in the developme...
Autores principales: | Selvais, Camille M., Davis‐López de Carrizosa, María A., Nachit, Maxime, Versele, Romain, Dubuisson, Nicolas, Noel, Laurence, Gillard, Justine, Leclercq, Isabelle A., Brichard, Sonia M., Abou‐Samra, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891981/ https://www.ncbi.nlm.nih.gov/pubmed/36513619 http://dx.doi.org/10.1002/jcsm.13148 |
Ejemplares similares
-
AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
por: Abou‐Samra, Michel, et al.
Publicado: (2020) -
AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017) -
AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice
por: Fang, Qian, et al.
Publicado: (2023) -
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
por: Nigro, Ersilia, et al.
Publicado: (2021) -
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
por: Xiao, Wen-Ze, et al.
Publicado: (2019)